For Alzheimer's patients, melatonin is typically used to improve sleep quality and reduce sundowning symptoms (evening agitation), with some evidence suggesting it may also modestly improve cognitive function, especially in mild cases.
Recommended Dosages for Alzheimer's Patients
Common effective doses range from 0.15 mg to 6 mg taken at bedtime, with many studies showing benefits at doses between 3 mg and 9 mg per night for sleep improvement and sundowning reduction146.
A typical starting dose for elderly dementia patients is:
Severe dementia: 0.25 to 0.5 mg
Moderate dementia: 0.5 to 1 mg
Mild dementia: 1 mg
These doses may be adjusted based on patient response3.
Long-term treatment (over 12 weeks to several months) with doses in the range of 3 to 9 mg nightly has been shown to improve sleep quality, reduce sundowning, and may help stabilize cognitive decline in some patients46.
Some clinical trials used 6 mg slow-release melatonin at bedtime for 4 weeks with positive effects on sleep and agitation4.
Higher doses (up to 50-100 mg) have been suggested experimentally for neuroprotection but are not yet established or recommended clinically5.
Reference:
Clinical Aspects of Melatonin Intervention in Alzheimer’s Disease Progression - PMC
Frontiers | Melatonin: Clinical Perspectives in Neurodegeneration